Clinical Cancer Bulletin, CCB
Clinical Cancer Bulletin, CCB
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Name:Zheng Wang (China)Introduction:
Dr. Wang is currently a professor of Zhongshan Hospital, Fudan University. He is currently appointed as the member of Committee of Chinese Society of Liver Cancer. He has been engaged in the clinical and applied basic research of liver cancer surgery for a long time. He has completed more than 4000 cases of liver resection and more than 300 cases of liver transplantation, and done ALPPS for the treatment of huge liver cancer that cannot be removed by traditional surgery. Entrusted by the National Health Commission in 2021, as the secretary general of the Compilation Expert Committee, he compiled the Guidelines for the Diagnosis and Treatment of Liver Cancer (2012 edition). He mainly focuses on molecular mechanism and intervention of liver cancer metastasis and recurrence. To date, he has published more than 30 peer-reviewed papers in international journals, including Hepatology, Molecular Cancer, Annals of Surgery and Clinical Cancer Research as the first or corresponding author. He has won the second prize of National Science and Technology Progress award, the first prize of Shanghai Science and Technology Progress Award, Mingzhi Life Science Award and other awards.
-
Name:Xinrong Yang (China)Introduction:
Professor. Yang is currently a Chief Physician and doctoral supervisor of Zhongshan hospital, Fudan university. He is the member of American Society of Clinical Oncology (ASCO), International liver cancer association (ILCA) and The International Liver Transplant Society (ILTS). He specializes in the diagnosis and surgical treatment of liver tumors as well as liver transplantation. He mainly focuses on the clinical and translational research of liver cancer,especially for liquid biopsy and personalized medicine of liver cancer. He is also committed to the construction of pre-clinical living biobank. Prof. Yang has presided over 18 major projects, including National Natural Science Foundation of China, Foundation of Ministry of Education of China, Shanghai Committee of Science and Technology, with a total research funding of more than 8 million RMB. He has been selected into Shanghai “Rising Stars of Medical Talent” Youth Development Program (Outstanding Youth Medical Talents), Shanghai Health System Outstanding Young Talents and other programs. Prof. Yang has obtained the Second-Class Prizes of The State Scientific and Technological Progress Award, the First-Class Prizes of Shanghai Scientific and Technological Progress Award, the First-Class Prizes of Huaxia Medical Science and Technology Award, Gold Prize of Shanghai Invention Award, and the First-Class Prizes of Natural Science Award of the Ministry of Education. To date, he has published over 68 peer-reviewed papers in journals including Cell, Nature, Lancet Oncology, GUT, Hepatology, etc. as the first author or the corresponding author. Prof. Yang has obtained 12 national invention patents and utility model patents, some of them have been successfully industrialized and transformed into clinical application.
-
-
-
-
-
-
-
Name:Minzhi Lv(China)Introduction:
● Statistician, Assistant researcher
● Department of Biostatistics, Zhongshan Hospital, Fudan University
● Member of The Evidence-based Medicine Center, Fudan University
● Member of Chinese Society of Clinical Oncology (CSCO) Young Expert Committee
● Coordinator of Chinese Clinical Epidemiology Collaboration Network (ChinaCLEN)
● Member of the Methodological Group of Clinical Epidemiology and Evidence-based Medicine of Shanghai Medical Association
Editors-in-Chief
Jia Fan (China)
Xiangdong Wang (Sweden)
Online ISSN 2791-3937
Competent unit Shanghai China Clinical Medicine Magazine House
Sponsored by Zhongshan Hospital Affiliated to Fudan University